Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 Standout
Prevalence of Metabolic Syndrome Risk Factors Among Young Adult Asian Indians
2005
In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
1994
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
1998 StandoutNature
Involvement of Human Blood Arylesterases and Liver Microsomal Carboxylesterases in Nafamostat Hydrolysis
2006
DNA Polymorphisms in Two Paraoxonase Genes (PON1 and PON2) Are Associated with the Risk of Coronary Heart Disease
1998
Management of acute organophosphorus pesticide poisoning
2007 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein
1997
Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men
1999
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Global burden of hypertension: analysis of worldwide data
2005 Standout
Acute wound healing
2003
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
2005 Standout
Selected major risk factors and global and regional burden of disease
2002 Standout
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
High density associated enzymes: their role in vascular biology
1998
The biology and function of fibroblasts in cancer
2016 Standout
Paraoxonase and coronary heart disease
1998
Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm
2008
Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma
2005
Cellular Cholesterol Efflux Mediated by Cyclodextrins
1995 Standout
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
1991 Standout
Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.
1996
Association of Low PON1 Type Q (Type A) Arylesterase Activity with Neurologic Symptom Complexes in Gulf War Veterans
1999
Calcium-dependent Human Serum Homocysteine Thiolactone Hydrolase
2000
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
The mechanosensory protein MEC-6 is a subunit of the C. elegans touch-cell degenerin channel
2002 StandoutNatureNobel
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Diabetes in Asia
2009 Standout
Presence of paraoxonase in human interstitial fluid
1997
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Type 2 diabetes in Asian Indian youth
2007
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Using Ethnicity as a Classification Variable in Health Research: Perpetuating the myth of biological determinism, serving socio-political agendas, or making valuable contributions to medical sciences?
1999
New Paraoxonase 1 Polymorphism I102V and the Risk of Prostate Cancer in Finnish Men
2003
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Hypoxia induces the activation of human hepatic stellate cells LX‐2 through TGF‐β signaling pathway
2006
Hydrolysis of platelet-activating factor by human serum paraoxonase
2001
Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification
1998
Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states
1998
The paraoxonase‐1 pathway is not a major bioactivation pathway of clopidogrelin vitro
2012
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
2008
Closing the gap in a generation: health equity through action on the social determinants of health
2008 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
HYPERLIPIDEMIA IN SOLID ORGAN TRANSPLANTATION
1997
Inflammation in atherosclerosis
2002 StandoutNature
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children
2002
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus
1998
Hypoxic induction ofCtgfis directly mediated by Hif-1
2004
Global burden of blood-pressure-related disease, 2001
2008 Standout
Early Wound Healing Exhibits Cytokine Surge Without Evidence of Hypoxia
2000
Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association
2018
Atherosclerosis
2000 StandoutNature
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Paraoxonase gene polymorphism and coronary artery disease in Indian subjects
1998
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Atherosclerosis
2001 Standout
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
1997
Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
1999
Hypoxia-enhanced Expression of the Proprotein Convertase Furin Is Mediated by Hypoxia-inducible Factor-1
2004
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Low Paraoxonase in Persian Gulf War Veterans Self-Reporting Gulf War Syndrome
2000
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis
2002
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes
1995
The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese
1998
Selective Plasma Hydrolysis of Glucocorticoid γ-Lactones and Cyclic Carbonates by the Enzyme Paraoxonase: An Ideal Plasma Inactivation Mechanism
1999
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Paraoxonase activity in two healthy populations with differing rates of coronary heart disease
2000
Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells.
2000
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Genetic Polymorphism of Paraoxonase and the Risk of Coronary Heart Disease
1997
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
2015 Standout
Effect of Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial Hypercholesterolemic Patients
2000
Emerging Epidemic of Cardiovascular Disease in Developing Countries
1998
Global Burden of Cardiovascular Diseases
2001
Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene
2000
Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins
1995
Inflammation and Atherosclerosis
2002 Standout
Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance
2001 StandoutNobel
Paraoxonase and Atherosclerosis
2001 Standout
Sudden Cardiac Death
1998 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Common Cholesteryl Ester Transfer Protein Mutations, Decreased HDL Cholesterol, and Possible Decreased Risk of Ischemic Heart Disease
2000
The Yin and Yang of Oxidation in the Development of the Fatty Streak
1996 Standout
Ethnic-Specific Obesity Cutoffs for Diabetes Risk: Cross-sectional Study of 490,288 UK Biobank Participants
2014
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
1996 StandoutScience
Paraoxonase-Gene Polymorphisms Associated with Coronary Heart Disease: Support for the Oxidative Damage Hypothesis?
1998
Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities
1998
Abdominal Obesity, Impaired Nonesterified Fatty Acid Suppression, and Insulin-Mediated Glucose Disposal Are Early Metabolic Abnormalities in Families With Premature Myocardial Infarction
1998
Global Burden of Cardiovascular Diseases
2001 Standout
Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF‐2 pathway
2015 StandoutNobel
Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study.
2000
Molecular physiology of reverse cholesterol transport.
1995
Increased Immunolocalization of Paraoxonase, Clusterin, and Apolipoprotein A-I in the Human Artery Wall With the Progression of Atherosclerosis
1997
Serum Paraoxonase After Myocardial Infarction
1999
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Real-Time Bioluminescence Imaging of Glycans on Live Cells
2010 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase Activities and Concentrations
2000
Works of M. Mackness being referenced
The effects of low‐dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women
1998
Absence of “A”-esterase activity in the serum of a patient with tangier disease
1989
Human Serum Paraoxonase
1998
A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with Type 1 (insulin-dependent) diabetes mellitus
1992
Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India
1995
An investigation of the role of lecithin: cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins
1991
Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits
2000
Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon
1997
Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells.
1994
Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy
1993
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations
1994